Quadrant Capital Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,068
| Closed | -$3.48K | – | 2367 |
|
2025
Q1 | $3.48K | Buy |
2,068
+1,220
| +144% | +$2.05K | ﹤0.01% | 2429 |
|
2024
Q4 | $1.38K | Buy |
848
+56
| +7% | +$91 | ﹤0.01% | 2546 |
|
2024
Q3 | $3.3K | Hold |
792
| – | – | ﹤0.01% | 2407 |
|
2024
Q2 | $4.33K | Hold |
792
| – | – | ﹤0.01% | 2333 |
|
2024
Q1 | $7.92K | Hold |
792
| – | – | ﹤0.01% | 2182 |
|
2023
Q4 | $3.23K | Buy |
792
+321
| +68% | +$1.31K | ﹤0.01% | 2373 |
|
2023
Q3 | $1.82K | Hold |
471
| – | – | ﹤0.01% | 2412 |
|
2023
Q2 | $2.81K | Hold |
471
| – | – | ﹤0.01% | 2341 |
|
2023
Q1 | $1.54K | Sell |
471
-30
| -6% | -$98 | ﹤0.01% | 2473 |
|
2022
Q4 | $1.98K | Buy |
501
+471
| +1,570% | +$1.86K | ﹤0.01% | 2419 |
|
2022
Q3 | $0 | Hold |
30
| – | – | ﹤0.01% | 2789 |
|
2022
Q2 | $0 | Sell |
30
-1
| -3% | – | ﹤0.01% | 2708 |
|
2022
Q1 | $0 | Buy |
+31
| New | – | ﹤0.01% | 2671 |
|